Por: CBS News Politics April 28, 2023
A replacement for a key COVID-19 antibody drug that has been used to protect immunocompromised Americans could be available within months, executives for drugmaker AstraZeneca said Thursday, after promising early results suggested it may work against all known variants of concern to date.The company's new experimental drug, currently named AZD3152, is being tested in a trial dubbed with the hope of preventing symptomatic infection in people... + full article
CNBC USA Business February 09, 2023
AstraZeneca has blockbuster projects in development that are set to make billions of dollars, according to its CFO.BSIP / Contributor / Getty ImagesDemand for Covid-19 vaccines has dropped as the pandemic enters its fourth year, but says it has blockbuster projects in... + más
Is the last 'Blockbuster' still open? The truth about Netflix show location | Newsweek
Last Blockbuster store, located in Oregon, to host contest winner for exclusive movie and game night | Fox Business
ABC News USA Health January 27, 2023
The U.S. Food and Drug Administration said Thursday it is withdrawing its emergency use authorization of a as a prevention tool because it is unlikely to be effective against variants that are currently circulating.Evusheld, which is made by British-Swedish pharmaceutical and... + más
FDA halts authorization of Evusheld, citing medication insufficient against viral COVID-19 variants | ABC7
FDA pauses US authorization for Eli Lilly's COVID treatment drug | Fox Business
NBC News USA Nation January 27, 2023
The Food and Drug Administration has withdrawn emergency use authorization for AstraZeneca’s Covid-19 antibody cocktail Evusheld as the treatment is not expected to neutralize the currently dominant XBB.1.5 subvariant of omicron. The FDA had limited Evusheld’s use... + más
FDA withdraws emergency use authorization of COVID drug because it is unlikely to be effective against new variants | ABC News
Time USA Health November 10, 2022
New lab data suggest that vaccines and prior infections may not offer enough protection against several new COVID-19 variants cropping up in the U.S. and around the world. Dr. David Ho, director of Columbia University’s Aaron Diamond AIDS Research Center (ADARC), and his team... + más
How Concerned Should You Be About Covid-19 ‘Scrabble' Variants? | NBC 6 South Florida
Quick and stealthy 'Scrabble variants' are poised to drive a winter Covid-19 surge | CNN
Time USA Health October 31, 2022
The U.S. led the world in quickly developing COVID-19 vaccines—one of the few bright spots in the country’s otherwise criticized response. But while injectable vaccines are effective in protecting people from getting sick with COVID-19, they are less able to block infection.... + más
Without a nasal vaccine, the U.S. edge in fighting Covid is on the line | Politico
Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab | Ars Technica
NBC 6 South Florida USA World October 26, 2022
monkeybusinessimages Getty Images Though BA.5 still accounts for most U.S. Covid-19 cases, percentages are rising for the other omicron variants circulating throughout the country, per the . The ones that are particularly concerning are BQ.1 and another related one called... + más
Biden Covid officials scramble to plan for Omicron subvariant threat | Politico
CNN USA Health October 20, 2022
CNN — A flurry of new Covid-19 variants appears to be gaining traction globally, raising fears of a winter surge. In the United States, these are BQ.1, BQ.1.1, BF.7, BA.4.6, BA.2.75 and BA.2.75.2. In other countries, the recombinant variant XBB has been rising quickly and... + más
What is storm surge, and what contributes to the deadly hurricane hazard? | CBS News
About iurex | Privacy Policy | Disclaimer |